Epirubicin HCl, a semisynthetic L-arabino derivative of doxorubicin, is an antineoplastic agent by inhibiting Topoisomerase.More at:https://www.bocsci.com/epirubicin-hydrochloride-cas-56390-09-1-item-84-71755.html